Show simple item record

Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)

dc.contributor.authorPlanchard, D
dc.contributor.authorGarassino, MC
dc.contributor.authorPaz-Ares, L
dc.contributor.authorFaivre-Finn, Corinne
dc.contributor.authorSpira, A
dc.contributor.authorGu, Y
dc.contributor.authorWadsworth, C
dc.contributor.authorWhiteley, J
dc.contributor.authorScott, M
dc.contributor.authorBoothman, AM
dc.contributor.authorRatcliffe, M
dc.contributor.authorWalker, J
dc.contributor.authorDennis, PA
dc.contributor.authorAntonia, SJ
dc.date.accessioned2019-10-04T09:48:23Z
dc.date.available2019-10-04T09:48:23Z
dc.date.issued2019en
dc.identifier.citationPlanchard D, Garassino MC, Paz-Ares L, Faivre-Finn C, Spira A, Gu Y, et al. 85O Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC). Ann Oncol. 2019;30(Supplement_2):32.en
dc.identifier.doi10.1093/annonc/mdz067.002en
dc.identifier.urihttp://hdl.handle.net/10541/622098
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz067.002en
dc.titlePrevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentDepartment of Medical Oncology, Thoracic Group, Institut Gustave Roussy, Villejuifen
dc.identifier.journalAnnals of Oncologyen
dc.description.noteen]
refterms.dateFOA2020-04-20T13:31:45Z


Files in this item

Thumbnail
Name:
561992.pdf
Size:
67.55Kb
Format:
PDF
Description:
From UNPAYWALL
Download

This item appears in the following Collection(s)

Show simple item record